PMC:7556165 / 15979-16262
Annnotations
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T57 | 179-188 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | Vitamin D | http://purl.bioontology.org/ontology/MEDDRA/10050713 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T76 | 179-188 | Chemical | denotes | Vitamin D | http://purl.obolibrary.org/obo/CHEBI_89324 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T44 | 192-200 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T45 | 248-258 | Species | denotes | Sars-CoV-2 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T106 | 51-260 | Sentence | denotes | More specifically, VDR activation would downregulate ACE2, thus affording a potential reason for the alleged beneficial role of Vitamin D in COVID-19 (section ACE2 and the Inflammatory Response to Sars-CoV-2). |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
470 | 45-49 | Gene | denotes | ACE2 | Gene:59272 |
471 | 70-73 | Gene | denotes | VDR | Gene:7421 |
472 | 104-108 | Gene | denotes | ACE2 | Gene:59272 |
473 | 210-214 | Gene | denotes | ACE2 | Gene:59272 |
475 | 248-258 | Species | denotes | Sars-CoV-2 | Tax:2697049 |
477 | 179-188 | Chemical | denotes | Vitamin D | MESH:D014807 |
479 | 192-200 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T1725 | 45-49 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T1726 | 70-73 | Protein | denotes | VDR | https://www.uniprot.org/uniprot/Q95MH5|https://www.uniprot.org/uniprot/Q922X0|https://www.uniprot.org/uniprot/Q5PSV3|https://www.uniprot.org/uniprot/Q28037|https://www.uniprot.org/uniprot/P49701|https://www.uniprot.org/uniprot/P48281|https://www.uniprot.org/uniprot/P13053|https://www.uniprot.org/uniprot/P11473|https://www.uniprot.org/uniprot/O42392|https://www.uniprot.org/uniprot/O13124|https://www.uniprot.org/uniprot/G3V1V9|https://www.uniprot.org/uniprot/B2R5Q1|https://www.uniprot.org/uniprot/A3RGC1 |
T1739 | 104-108 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T1740 | 210-214 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T54 | 192-200 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T55 | 248-258 | Disease | denotes | Sars-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T40 | 223-244 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | Inflammatory Response |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T41 | 223-244 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | Inflammatory Response |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
470 | 45-49 | Gene | denotes | ACE2 | Gene:59272 |
471 | 70-73 | Gene | denotes | VDR | Gene:7421 |
472 | 104-108 | Gene | denotes | ACE2 | Gene:59272 |
473 | 210-214 | Gene | denotes | ACE2 | Gene:59272 |
475 | 248-258 | Species | denotes | Sars-CoV-2 | Tax:2697049 |
477 | 179-188 | Chemical | denotes | Vitamin D | MESH:D014807 |
479 | 192-200 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T106 | 51-260 | Sentence | denotes | More specifically, VDR activation would downregulate ACE2, thus affording a potential reason for the alleged beneficial role of Vitamin D in COVID-19 (section ACE2 and the Inflammatory Response to Sars-CoV-2). |